Yield10 Bioscience, Inc. (YTEN)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 60 Thousand USD | -86.67% |
| 2022 | 450 Thousand USD | -26.71% |
| 2021 | 614 Thousand USD | -23.15% |
| 2020 | 799 Thousand USD | -0.87% |
| 2019 | 806 Thousand USD | 44.96% |
| 2018 | 556 Thousand USD | -41.1% |
| 2017 | 944 Thousand USD | -18.55% |
| 2016 | 1.15 Million USD | -55.32% |
| 2015 | 2.59 Million USD | -7.36% |
| 2014 | 2.8 Million USD | -48.09% |
| 2013 | 5.39 Million USD | -87.25% |
| 2012 | 42.31 Million USD | 2869.54% |
| 2011 | 1.42 Million USD | 218.08% |
| 2010 | 448 Thousand USD | -68.56% |
| 2009 | 1.42 Million USD | -8.36% |
| 2008 | 1.55 Million USD | -7.61% |
| 2007 | 1.68 Million USD | -63.33% |
| 2006 | 4.59 Million USD | 65.05% |
| 2005 | 2.78 Million USD | -24.39% |
| 2004 | 3.67 Million USD | 54.34% |
| 2003 | 2.38 Million USD | 19.82% |
| 2002 | 1.98 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 450 Thousand USD | 50.0% |
| 2024 Q1 | 300 Thousand USD | 400.0% |
| 2023 FY | 60 Thousand USD | -86.67% |
| 2023 Q2 | - USD | -100.0% |
| 2023 Q4 | 60 Thousand USD | 0.0% |
| 2023 Q1 | 60 Thousand USD | -31.03% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q2 | 103 Thousand USD | -30.87% |
| 2022 FY | 450 Thousand USD | -26.71% |
| 2022 Q3 | 111 Thousand USD | 7.77% |
| 2022 Q4 | 87 Thousand USD | -21.62% |
| 2022 Q1 | 149 Thousand USD | -1.97% |
| 2021 FY | 614 Thousand USD | -23.15% |
| 2021 Q2 | 174 Thousand USD | -11.22% |
| 2021 Q1 | 196 Thousand USD | 0.51% |
| 2021 Q3 | 92 Thousand USD | -47.13% |
| 2021 Q4 | 152 Thousand USD | 65.22% |
| 2020 FY | 799 Thousand USD | -0.87% |
| 2020 Q1 | 179 Thousand USD | 27.86% |
| 2020 Q2 | 221 Thousand USD | 23.46% |
| 2020 Q3 | 204 Thousand USD | -7.69% |
| 2020 Q4 | 195 Thousand USD | -4.41% |
| 2019 FY | 806 Thousand USD | 44.96% |
| 2019 Q1 | 124 Thousand USD | -8.15% |
| 2019 Q2 | 318 Thousand USD | 156.45% |
| 2019 Q3 | 224 Thousand USD | -29.56% |
| 2019 Q4 | 140 Thousand USD | -37.5% |
| 2018 FY | 556 Thousand USD | -41.1% |
| 2018 Q3 | 76 Thousand USD | -73.33% |
| 2018 Q4 | 135 Thousand USD | 77.63% |
| 2018 Q1 | 60 Thousand USD | -42.31% |
| 2018 Q2 | 285 Thousand USD | 375.0% |
| 2017 Q4 | 104 Thousand USD | -53.36% |
| 2017 FY | 944 Thousand USD | -18.55% |
| 2017 Q3 | 223 Thousand USD | -23.89% |
| 2017 Q2 | 293 Thousand USD | -9.57% |
| 2017 Q1 | 324 Thousand USD | -4.99% |
| 2016 FY | 1.15 Million USD | -55.32% |
| 2016 Q4 | 341 Thousand USD | -27.91% |
| 2016 Q3 | 473 Thousand USD | -83.06% |
| 2016 Q2 | 2.79 Million USD | 313.78% |
| 2016 Q1 | 675 Thousand USD | 36.09% |
| 2015 Q1 | 645 Thousand USD | -24.65% |
| 2015 Q4 | 496 Thousand USD | -30.04% |
| 2015 Q3 | 709 Thousand USD | -4.7% |
| 2015 Q2 | 744 Thousand USD | 15.35% |
| 2015 FY | 2.59 Million USD | -7.36% |
| 2014 Q4 | 856 Thousand USD | 35.44% |
| 2014 FY | 2.8 Million USD | -48.09% |
| 2014 Q1 | 1.06 Million USD | 20.11% |
| 2014 Q2 | 1.17 Million USD | 9.45% |
| 2014 Q3 | 632 Thousand USD | -45.98% |
| 2013 Q1 | 1.94 Million USD | 39.08% |
| 2013 Q2 | 1.7 Million USD | -12.2% |
| 2013 FY | 5.39 Million USD | -87.25% |
| 2013 Q3 | 855 Thousand USD | -49.88% |
| 2013 Q4 | 890 Thousand USD | 4.09% |
| 2012 Q2 | 923 Thousand USD | -97.65% |
| 2012 FY | 42.31 Million USD | 2869.54% |
| 2012 Q4 | 1.39 Million USD | 107.27% |
| 2012 Q3 | 674 Thousand USD | -26.98% |
| 2012 Q1 | 39.32 Million USD | 8857.18% |
| 2011 Q2 | 191 Thousand USD | -41.41% |
| 2011 Q1 | 326 Thousand USD | 188.5% |
| 2011 Q3 | 469 Thousand USD | 145.55% |
| 2011 Q4 | 439 Thousand USD | -6.4% |
| 2011 FY | 1.42 Million USD | 218.08% |
| 2010 FY | 448 Thousand USD | -68.56% |
| 2010 Q3 | 46 Thousand USD | -57.8% |
| 2010 Q1 | 180 Thousand USD | -12.2% |
| 2010 Q2 | 109 Thousand USD | -39.44% |
| 2010 Q4 | 113 Thousand USD | 145.65% |
| 2009 FY | 1.42 Million USD | -8.36% |
| 2009 Q4 | 205 Thousand USD | -66.45% |
| 2009 Q1 | 261 Thousand USD | -34.59% |
| 2009 Q2 | 348 Thousand USD | 33.33% |
| 2009 Q3 | 611 Thousand USD | 75.57% |
| 2008 Q3 | 351 Thousand USD | -12.47% |
| 2008 Q4 | 399 Thousand USD | 13.68% |
| 2008 Q2 | 401 Thousand USD | -0.74% |
| 2008 Q1 | 404 Thousand USD | -54.5% |
| 2008 FY | 1.55 Million USD | -7.61% |
| 2007 FY | 1.68 Million USD | -63.33% |
| 2007 Q3 | 180 Thousand USD | -3.74% |
| 2007 Q2 | 187 Thousand USD | -56.41% |
| 2007 Q1 | 429 Thousand USD | 20.17% |
| 2007 Q4 | 888 Thousand USD | 393.33% |
| 2006 Q1 | 3.08 Million USD | 384.47% |
| 2006 Q2 | 1.9 Million USD | -38.18% |
| 2006 Q3 | 423 Thousand USD | -77.79% |
| 2006 Q4 | 357 Thousand USD | -15.6% |
| 2006 FY | 4.59 Million USD | 65.05% |
| 2005 Q2 | 807.46 Thousand USD | 15.12% |
| 2005 Q1 | 701.41 Thousand USD | -23.72% |
| 2005 FY | 2.78 Million USD | -24.39% |
| 2005 Q4 | 636.05 Thousand USD | 0.0% |
| 2005 Q3 | 636.05 Thousand USD | -21.23% |
| 2004 Q1 | 919.55 Thousand USD | 0.0% |
| 2004 FY | 3.67 Million USD | 54.34% |
| 2004 Q2 | 919.55 Thousand USD | 0.0% |
| 2004 Q4 | 919.55 Thousand USD | 0.0% |
| 2004 Q3 | 919.55 Thousand USD | 0.0% |
| 2003 FY | 2.38 Million USD | 19.82% |
| 2002 FY | 1.98 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 464.82 Million USD | 99.987% |
| Muliang Viagoo Technology, Inc. | 8.65 Million USD | 99.307% |
| N2OFF, Inc. | 263.44 Thousand USD | 77.225% |
| Arcadia Biosciences, Inc. | 5.33 Million USD | 98.874% |